header-logo header-logo

The final chance

31 March 2017 / David Locke
Issue: 7740 / Categories: Features
printer mail-detail
nlj_7740_locke

The law should not underestimate the desire of terminally ill patients to make a final & important contribution to medical advancement, says David Locke​

  • Why should a properly informed patient not be able to exercise their autonomy to elect for novel medical treatment

There are clearly many occasions when being first is an advantage, but just occasionally it is rather less obviously a benefit. One cannot, for example, easily conceive of how it might feel to be the first person put under anaesthetic to undergo a new experimental surgical procedure. It must be times like that when the benefits of evidence based medicine come into a very stark and individual perspective. After all, isn’t that what evidence-based medicine is when reduced to the personal level: the idea that enough people have already had it done to them so that you can be reasonably sure what the outcome is likely to be for you ?

Nonetheless, someone always has to be first and for every patient who undergoes a new treatment there must be a

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Gilson Gray—Linda Pope

Gilson Gray—Linda Pope

Partner joins family law team inLondon

Jackson Lees Group—five promotions

Jackson Lees Group—five promotions

Private client division announces five new partners

Taylor Wessing—Max Millington

Taylor Wessing—Max Millington

Banking and finance team welcomes partner in London

NEWS
The landmark Supreme Court’s decision in Johnson v FirstRand Bank Ltd—along with Rukhadze v Recovery Partners—redefine fiduciary duties in commercial fraud. Writing in NLJ this week, Mary Young of Kingsley Napley analyses the implications of the rulings
Barristers Ben Keith of 5 St Andrew’s Hill and Rhys Davies of Temple Garden Chambers use the arrest of Simon Leviev—the so-called Tinder Swindler—to explore the realities of Interpol red notices, in this week's NLJ
Mazur v Charles Russell Speechlys [2025] has upended assumptions about who may conduct litigation, warn Kevin Latham and Fraser Barnstaple of Kings Chambers in this week's NLJ. But is it as catastrophic as first feared?
Lord Sales has been appointed to become the Deputy President of the Supreme Court after Lord Hodge retires at the end of the year
Limited liability partnerships (LLPs) are reportedly in the firing line in Chancellor Rachel Reeves upcoming Autumn budget
back-to-top-scroll